This year’s top ophthalmic business article discussed ophthalmology’s venture into the metaverse.

Read about this and other ophthalmic business news from 2022 below.

Ophthalmology takes the plunge into the metaverse

The 2022 Digital Ophthalmic Society meeting was the first ever eye care conference to be held in a space station, or at least that is what it looked like. Read more.

Genentech voluntarily recalls Susvimo ocular implant

Genentech is voluntarily recalling the Susvimo implant and insertion tool for the treatment of wet age-related macular degeneration in the U.S. Read more.

VIDEO: Ophthalmologist returning from Ukraine appeals for used medical supplies

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Emil Chynn, MD, MBA, discusses a recent trip he took delivering medical supplies to Ukraine. Watch here.

iStent infinite cleared by FDA

The FDA granted 510(k) clearance for the Glaukos iStent infinite trabecular micro-bypass system to reduce IOP as a stand-alone procedure for uncontrolled primary open-angle glaucoma. Read more.

FDA approves Cimerli as interchangeable biosimilar to Lucentis

The FDA approved Cimerli from Coherus BioSciences as a biosimilar to and interchangeable with Lucentis. Read more.